Go to the list of all blogs
Anna G's Avatar
published in Blogs
Jul 29, 2024

Newmont Mining ($NEM) Faces a Setback Amidst Market Volatility 📉💎

Market Dynamics: A Shifting Landscape

This week saw Newmont (NEM) retreat -6.68% to close at $34.78, underlining a week of challenges for the Precious Metals Industry. In a sector where 55.26% of stocks displayed an uptrend, NEM’s downturn stands out, urging a closer look from traders and investors alike.


Discover the Top 10 AI Robots - 

 If you're interested in AI trading and want to explore the top 10 AI robots, you can find them at the following links:

  1. Top 10 AI Robots  - SORT BY Sharper 
  2. Top 10 AI Robots  - SORT BY  30-day 
  3. Top 10 AI Robots  - SORT BY  All Time 

 

Earnings Snapshot: A Missed Target

Newmont's October 26 earnings report revealed a 36 cents EPS, trailing behind the anticipated 43 cents. Despite this miss, Newmont upholds a substantial market cap of $41.99B, bolstered by 2.23M shares in circulation.

Dividend Dispatch: Rewarding Shareholders

Amidst the stock’s performance, NEM maintained its shareholder commitment with a $0.40 per share dividend. Remember, to capture upcoming dividends, investors should hold shares before the ex-dividend date, which was September 06, 2023, for the last payout.

Industry Titans: Newmont stands among peers like Barrick Gold and Wheaton Precious Metals, all formidable entities in an industry that extracts and refines the earth's rarest treasures.

Sector Analysis: The Precious Metals Industry is diverse, spanning from gold to palladium, with applications from ornate jewelry to high-tech gadgets. Firms like Newmont, Barrick, and Freeport-McMoRan lead this space, where metals often command premium market prices.

Capitalization Context: With industry average market cap at 931.3M, Newmont’s position is robust. ZIJMY tops the valuation charts at 47.49B, setting a benchmark for success.

Pricing Pulse: Weekly growth remained static at 0%, with monthly and quarterly movements registering a slight decline. TRRFF's massive 572% surge was the highlight, overshadowing AUHIF's steep -80% drop.

Volume Variance: Trading volumes saw a modest 6% weekly uptick. Monthly and quarterly figures reflect more activity, potentially signaling increased investor interest or strategic position adjustments.

Fundamental Focus:

Here’s how Newmont stands on fundamental metrics:

  • Valuation Rating: 53
  • P/E Growth Rating: 75
  • Price Growth Rating: 51
  • SMR Rating: 89
  • Profit Risk Rating: 87
  • Seasonality Score: -3

Despite the stock’s recent -7.40% slip and a -12.18% drawdown, A.I.dvisor points towards a potential upside with 22.09% odds, hinting at possible gains for those betting against the stock.

Looking Ahead: With the market's ebb and flow, Newmont's trajectory could serve as a barometer for the precious metals sector. Investors should watch for macroeconomic signals, industry trends, and company fundamentals to navigate this terrain.

Traders and investors, keep your portfolios aligned with the market's pulse, and let’s stay attuned to the shifts and swings of the Precious Metals Industry. 🔍💠📊

Interact to see
Advertisement
HIMS shares surged approximately +43.85% in premarket trading on Monday, March 9, 2026, rising from a prior close of $15.74 to around $22.80. Primary catalyst: Novo Nordisk officially ended its patent infringement lawsuit against Hims & Hers and announced a landmark partnership to distribute branded Wegovy through the Hims platform at $599/month.
XENE shares surged approximately +45.93% in premarket trading on March 9, 2026, one of the largest single-session moves in the company's history. The primary catalyst: Xenon announced positive topline Phase 3 X-TOLE2 results for its lead drug candidate azetukalner in focal onset seizures (FOS), meeting the primary endpoint with overwhelming statistical significance.
Shares of OLMA dropped approximately 41% in Monday's session, one of the steepest single-day declines in the company's history. The primary catalyst was Roche's Phase 3 persevERA trial failure — a late-stage study of giredestrant, a closely competing selective estrogen receptor degrader (SERD), which missed its primary endpoint of statistically significant improvement in progression-free survival.
RLMD shares surged approximately +40% at the open on March 9, 2026, rising from a prior close of $4.45 to approximately $6.23, driven by a major clinical trial readout. The primary catalyst was the announcement of 12-month interim data from the Phase 2 trial of NDV-01, Relmada's lead oncology candidate, in patients with high-risk non-muscle invasive bladder cancer (NMIBC) — results that significantly exceeded historical benchmarks.
CRCL surged +8.66% on Monday, March 9, 2026, rising from a prior close of $101.94 to trade at $110.77 intraday. The primary catalyst is a landmark stablecoin milestone: Circle's USDC overtook Tether as the dominant stablecoin by transfer volume, accounting for approximately 70% of all stablecoin transfer activity as total stablecoin transfers hit $1.8 trillion in February.
Carnival Corporation (CCL) shares fell approximately -7.60% in Monday's session, dropping from a Friday close of $25.79 to around $23.83. The primary catalyst is a broad market sell-off driven by intensifying recession fears, with the S&P 500 and consumer discretionary names bearing the brunt of the pressure.
Shares of Bloom Energy (BE) are surging approximately +10.30% in Monday's session, rebounding sharply from a steep -15.50% selloff on Friday, March 6, 2026. Friday's decline was triggered by an Oracle-OpenAI data center project update that spooked energy infrastructure investors; Monday's move reflects aggressive dip-buying and a sentiment reset.
IGV has rallied about 8–9% in the last 6 trading days, while SOXX has dropped about 8%, giving software a +16.6 percentage‑point edge—the largest 6‑day software‑over‑semi outperformance ever.[barchart]​ This comes right after software lagged semis by almost −15 percentage points into late January, the widest gap since 2008, and as hedge‑fund short exposure to U.S. software and services hit a record ~3.8% of market cap.
Crude’s explosive war‑driven spike faded on March 9 because the market suddenly started to price less extreme, shorter‑lived supply risk and more policy intervention, not a multi‑month shortage. WTI, which had briefly traded above 115–120 dollars on Iran‑war headlines and Strait of Hormuz fears, slid back toward the high‑80s as traders digested G7 reserve‑release talk, Trump’s comments about a “brief” war, and the reality that prices had run far ahead of fundamentals.
Shares of ARQ plunged approximately 27.50% in premarket trading on March 10, 2026, from a prior close of $3.20 to roughly $2.32. The primary catalyst was a deeply disappointing Q4 2025 earnings report, which revealed a net loss of $50.0 million for the quarter versus a net loss of $1.3 million in Q4 2024.
RAIL shares fell approximately 15% in premarket trading on March 10, 2026, following a steep after-hours reaction to disappointing Q4 2025 earnings results released after the close on March 9. The primary catalyst was a significant revenue miss: Q4 revenue came in at $125.6 million, well below consensus estimates near $144–$160 million, representing an 8.8% year-over-year decline.
ZVRA shares surged approximately +17.86% on March 10, 2026, driven by a blockbuster Q4 and full-year 2025 earnings report released before the market open. Primary catalyst: Q4 2025 EPS of $0.19 crushed the consensus estimate of $0.05 — a 280% beat — while revenue of $34.1 million exceeded forecasts by 21.57%.
LITE surged +14.73% on Monday, March 9, 2026, closing at $640.69 versus a prior close of $558.44 on March 6. The primary catalyst was the landmark $2 billion strategic investment by NVIDIA announced March 2, with the market continuing to price in its full implications following a brief post-announcement pullback.
Shares of BNTX fell approximately 22% on Tuesday, March 10, 2026, following a dual shock of disappointing full-year guidance and a surprise leadership upheaval. The primary catalyst was BioNTech's Q4 2025 earnings report, which included a 2026 revenue outlook of €2.0–€2.3 billion — well below analyst consensus and signaling continued pressure from declining COVID-19 vaccine demand.
CNC shares fell approximately 10% during Tuesday's session, extending a prolonged selloff in the managed care sector. The primary catalyst is intensifying investor concern over federal Medicaid and ACA funding cuts tied to the "One Big Beautiful Bill Act" (OBBBA), which threatens to shrink the government-sponsored insurance pools that Centene depends on for the majority of its revenue.
Technology recently peaked near 35% of the S&P 500 and has slipped over the last year, while Energy plus Materials remain near historically low combined weight at roughly 6%, which suggests the gap is still unusually wide.
Average daily equity purchases by retail investors on S&P 500 down days in 2026 are at the highest level on record, running about 100% above the peak intensity seen during the 2021 meme‑stock boom.
Over the past two weeks, PLTR has climbed from roughly the high‑130s to the mid‑150s, a gain of about 12–14%, with a series of strong up days between March 2 and March 6.
AVAV shares dropped approximately 10% in premarket trading on March 11, 2026, following a disappointing Q3 fiscal 2026 earnings report released after the prior session's close. Q3 revenue of $408.0 million came in far below analyst consensus of approximately $475–$488 million, representing a massive top-line miss.
KOS shares are down approximately 20% in premarket trading on March 11, 2026, having shed roughly 20.31% across the last two sessions (Tuesday close and premarket Wednesday). The primary catalyst is Kosmos Energy's announcement of a massive $185.25 million public equity offering priced at $1.90 per share — a steep discount to recent trading levels.